| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $27.56M | $19.05M | $17.53M | $13.88M | $14.93M | $7.34M |
| R&D | $19.97M | $14.70M | $12.88M | $9.06M | $7.73M | $4.08M |
| SG&A | $7.59M | $4.35M | $4.65M | $4.82M | $7.20M | $3.25M |
| Operating Income | -$27.56M | -$19.05M | -$17.53M | -$13.88M | -$14.93M | -$7.34M |
| Interest Expense | – | – | – | – | $2.75M | -$39.79K |
| Tax Expense | $2.00K | $2.00K | $2.00K | $1.60K | $1.60K | $1.60K |
| Net Income | -$28.24M | -$18.82M | -$17.47M | -$13.88M | -$18.63M | -$7.38M |
| EPS (basic) | -12.3600 | -0.5100 | -0.7800 | -1.2800 | -2.7400 | – |
| EPS (diluted) | -12.3600 | -0.5100 | -0.7800 | -1.2800 | -2.7400 | – |
| Shares (diluted) | $2.29M | $37.01M | $22.38M | $10.88M | $6.81M | – |